Researchers have been excited about this new drug, a innovative dual agonist showing remarkable data in clinical trials for size loss . It acts by modulating two hormones : GLP-1 and GIP, that , when engaged , help regulate cravings and improve metabolism . Preliminary findings demonstrate substantial weight reduction and potential improvements for